COMPARISON OF COMPLEMENT DEPENDENT CYTOTOXICITY AGAINST PERIPHERAL-BLOOD LYMPHOCYTES (CDC-PBL) BY CR-51 RELEASE WITH COMPLEMENT DEPENDENT CYTOTOXICITY AGAINST B-CELLS (CDC-B) BY DYE EXCLUSION

被引：0
|
作者：
KOVITHAVONGS, T
SCHLAUT, J
DOSSETOR, JB
机构：
[1] UNIV ALBERTA, MRC, TRANSPLANTATION GRP, EDMONTON, ALBERTA, CANADA
[2] UNIV ALBERTA, DEPT MED, EDMONTON, ALBERTA, CANADA
[3] UNIV ALBERTA, DEPT LAB MED, EDMONTON, ALBERTA, CANADA
来源：
CLINICAL RESEARCH | 1976年 / 24卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A673 / A673
页数：1
相关论文
共 10 条
  • [1] COMPARISON OF COMPLEMENT DEPENDENT B-CELL CYTOTOXICITY (CDC-B) WITH ANTIBODY MEDIATED CELLULAR CYTOTOXICITY (ADCC-B) IN DETECTION OF IA IN WORKSHOP FAMILY WITH CROSSING OVER OUTSIDE HLA-D
    DOSSETOR, JB
    KOVITHAVONGS, T
    SCHLAUT, JW
    MARCHUK, L
    PAZDERKA, F
    TISSUE ANTIGENS, 1977, 10 (03): : 126 - 126
  • [2] ANTIBODY-DEPENDENT AND COMPLEMENT-DEPENDENT CELL INJURY ASSAYED BY CR-51 RELEASE FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRETREATED WITH LIPOPOLYSACCHARIDE
    REPO, H
    LEIRISALOREPO, M
    NURMINEN, M
    MAKELA, PH
    INFECTION AND IMMUNITY, 1987, 55 (03) : 507 - 512
  • [3] Type I CD20 antibodies take over the B-cell receptor for complement-dependent cytotoxicity (CDC) of malignant B cells
    Engelberts, Patrick J.
    Voorhorst, Marleen
    Schuurman, Janine
    van Meerten, Tom
    Bakker, Joost M.
    Vink, Tom
    Mackus, Wendy J. M.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Beurskens, Frank J.
    IMMUNOBIOLOGY, 2012, 217 (11) : 1218 - 1218
  • [4] Quantitative analyses reveal substantial differences between Ofatumumab (OFA) and Rituximab (RTX) in mediating Complement-Dependent Cytotoxicity (CDC) of B cell lines and Chronic Lymphocytic Leukemia (CLL) cells
    Taylor, P.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1711 - 1712
  • [5] Binding of Submaximal C1q to B Cells Opsonized with Anti-CD20 Mabs Ofatumumab (OFA) or Rituximab (RTX) Promotes Complement Dependent Cytotoxicity (CDC), and Considerably Higher Levels of CDC Are Induced by OFA Than by RTX
    Taylor, Ronald P.
    Pawhiczkowycz, Andrew W.
    Lindorfer, Margaret A.
    de Winkel, Jan G. J. van
    Beurskens, Frank J.
    Parren, Paul W. H. I.
    BLOOD, 2008, 112 (11) : 560 - 560
  • [6] Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX
    Pawluczkowycz, Andrew W.
    Beurskens, Frank J.
    Beum, Paul V.
    Lindorfer, Margaret A.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Taylor, Ronald P.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (01): : 749 - 758
  • [7] COMPLEMENT DEPENDENT (C'DCC) AND INDEPENDENT (C'ICC) CYTOTOXICITY OF C3HF-HEHA MOUSE SPLEEN-CELLS SENSITIZED AGAINST SHEEP RED BLOOD-CELLS (SRBC) - EFFECTS OF CYTOCHALASIN-B
    COHEN, S
    MAWAS, C
    MIHICH, E
    FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 781 - &
  • [8] TCR–like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus–transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants
    Junyun Lai
    Joanna Ai Ling Choo
    Wei Jian Tan
    Chien Tei Too
    Min Zin Oo
    Manuel A. Suter
    Fatimah Bte Mustafa
    Nalini Srinivasan
    Conrad En Zuo Chan
    Andrew Guo Xian Lim
    Youjia Zhong
    Soh Ha Chan
    Brendon J. Hanson
    Nicholas R. J. Gascoigne
    Paul A. MacAry
    Scientific Reports, 7
  • [9] rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
    Ge, Xiaowen
    Wu, Lin
    Hu, Weiguo
    Fernandes, Stacey
    Wang, Chun
    Li, Xu
    Brown, Jennifer R.
    Qin, Xuebin
    CLINICAL CANCER RESEARCH, 2011, 17 (21) : 6702 - 6711
  • [10] TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants
    Lai, Junyun
    Choo, Joanna Ai Ling
    Tan, Wei Jian
    Too, Chien Tei
    Oo, Min Zin
    Suter, Manuel A.
    Mustafa, Fatimah Bte
    Srinivasan, Nalini
    Chan, Conrad En Zuo
    Lim, Andrew Guo Xian
    Zhong, Youjia
    Chan, Soh Ha
    Hanson, Brendon J.
    Gascoigne, Nicholas R. J.
    MacAry, Paul A.
    SCIENTIFIC REPORTS, 2017, 7
1